StockWatch
·
HARSHA ENGINEERS INTERNATIONAL LTD · QQ1 FY-2027 · THE CALL

Strong topline growth masking margin pressure from commodity headwinds

The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.

Q1 FY27 resultsHARSHAHarsha Engineers International Ltd17 Aug 2026 · 6 min read
Verdict

Hold

confidence 6/10

Credibility

Grade B

Hit prior double-digit revenue guidance; margin guidance being walked down cautiously (24% → 20-22%); subsidiaries still loss-making

Short-term outlook

Cautiously Optimistic

next 1–2 quarters

Long-term outlook

Optimistic

multi-year

Strong revenue delivery (+25% YoY) and near-term growth drivers (Bushing 35%, Stamping 31%, CapEx ramp) offset by PAT decline despite topline growth and aggressive FY27 targets. Margin recovery hinges on RM pass-through timing and Advantek needing 3.25x growth in 9 months.

₹457.4 Cr

Revenue · +25.2% YoY

₹37.4 Cr

Reported PAT · −1.5% YoY

Compressing

Margins · vs guidance: Mixed

Did the claims hold up?

Management's claims vs. the numbers

Satisfactory Q1 performance in line with management plan

OVERSTATED

Revenue +25% YoY exceeded guidance; PAT flat/down -1.5% despite topline growth

Pass-through of 8% RM increase will normalize margins in Q2

Partial

OPM fell 150 bps YoY; margin recovery timing unverified, dependent on customer acceptance

Strong 21% growth in India Engineering with 6% QoQ growth

MET

Confirmed; India segment delivered 21% YoY and 6% QoQ despite macro headwinds

Bushing targeting 30% growth FY27 with strong visibility

MET

Q1 delivered 35% YoY; but order book and pipeline assurances lack specifics

Advantek ₹140 Cr+ revenue target for FY27

MISS

Q1 ₹30 Cr, FY26 ₹43 Cr; requires 3.25x growth in 3 quarters, highly aggressive

Earnings quality

What changed since the last call

Deltas vs. the prior call

India guidance upgraded to high-teens

Upgrade

Prior mid-teens (14-15%), now high-teens (16%+); Q1 delivered 21% supports upgrade but Q4 FY26 was typically strongest

Japan customer growth downgraded to 10%

Downgrade

Q1 showed 25% growth (₹21 Cr) but full-year guidance capped at 10% (₹80 Cr); management cited slow project pipeline

Margin guidance narrowed to 20-22% band

Downgrade

Standalone Q1 was 24%; new guidance reflects RM cost impact and capex ramp costs; prior was 'maintain current profile'

Romania losses timeline pushed

Neutral

Combined China + Romania target of ₹2-3 Cr loss from ₹10 Cr in FY26; breakeven now 'maybe next year' vs prior expectation

The Q&A

Q&A was pointed: analysts pressed on Romania's path to profitability (management hedged with 'gradually reduce losses'), large-Cages Q1 weakness (blamed capacity ramp), and Japan guidance downgrade (acknowledged 'laggard in terms of growth'). Management held firm on targets but offered minimal specificity on subsidiary recovery mechanics.

The exchanges that mattered

Revenue growth drivers — Varun Jain, Dolat Capital

Answered

Broad-based: industrial demand strengthening globally + European recovery. Growth across all segments.

FY27 growth guidance — Varun Jain, Dolat Capital

Answered

No, 20% is very tough stretch. Mid-to-high-teens India, low-teens consolidated expected.

Margin compression — Varun Jain, Dolat Capital

Answered

Across the board: brass, copper, zinc, steel, polymer. Global conditions impacted all materials.

Foreign subsidiary margins — Varun Jain, Dolat Capital

Partial

RM costs continuing to rise, negating revenue upside. Romania FX loss ₹2 Cr also impacted.

Romania recovery plan — Amit Anwani, PL Capital

Partial

Working on it but limited numbers so far. Pipeline improving toward cages; combined loss ₹2-3 Cr by FY27 end target.

Bushing growth sustainability — Amit Anwani, PL Capital

Answered

Conversion effect + wallet share. Expect conversion to continue 1-2 years; addition of new products also supporting.

Large-size Cages weakness — Amit Anwani, PL Capital

Answered

Q1 was aberration due to capacity ramp-up at new facility. Strong order book and pipeline support 50% confidence.

CapEx progress update — Vaibhav Shah, Equirus Securities

Answered

China Phase-2 on track for Q3 FY28 commissioning. Bhayla Phase-2 construction rolling; expect ₹50-80 Cr this year.

Core Cages growth (excl. new products) — Manish Goyal, ThinkWise

Answered

Yes, driven by Indian economy growth + outsourcing + customer export plants. Should match bearing industry growth 10%+ at least.

Japan customer guidance — Varun Jain, Dolat Capital

Partial

Last year ₹72 Cr; expect same run-rate continue, so ₹80 Cr = ~10%. Japan very slow; many projects under discussion.

Solar business volatility — Varun Jain, Dolat Capital

Answered

Project-based business; Q4 typically strong (depreciation benefit). FY27 revenue ₹200 Cr ~₹7-8% EBITDA margin.

Customer concentration — Varun Jain, Dolat Capital

Answered

All named are top customers. Top 10 customers ~80% of revenue spread across 80+ plants globally. High wallet share 80-90% with major customers.

Advantek margin expectations — Uttam Purohit, VVD Asset Mgmt

Answered

Q1 ~9% (impacted by material costs). Will match India EBITDA margin next year. Currently in ramp phase.

China delay implications — Varun Jain, Dolat Capital

Answered

China will see low growth in FY28; benefit accelerates from FY29 onward.

Margin recovery path — Jason Soans, IDBI Capital

Answered

Yes, RM costs will reduce margin percentage despite absolute value increase; also capex ramp-up costs impact FY27.

PAT outgrowth thesis — Resham Jain, VBD Asset Mgmt

Answered

Yes, especially this year. Q-o-Q Advantek losses will reduce dramatically; if Romania turns around, even more leverage.

Guidance

Forward guidance and management's confidence

FY27 India high-teens growth (upgraded from mid-teens)

High

Q1 delivered 21% YoY supports high-teens; driven by Bushing 30%, Stamping 30%, core Cages 10%+ growth

FY27 consolidated low-to-medium teens growth

Medium

10-15% band; India high-teens + foreign low single-digit (China 10%, Romania <10%) blends to low-teens

Advantek ₹140 Cr+ revenue FY27 (vs ₹43 Cr FY26)

Low

Requires 3.25x growth in 9 months; Q1 only ₹30 Cr; management confident but execution risk high

Bushing 30% growth FY27 (base ₹127 Cr FY26)

High

Q1 ₹34 Cr (+35% YoY); strong visibility on orders; conversion effects expected to continue 1-2 years

Stamping 30% growth FY27 (base ₹60 Cr FY26)

High

Q1 ₹90 Cr (inconsistent with base; likely includes new products); new product pipeline strong (AC, railways)

India margin 20-22% sustainable (vs 24% Q1 standalone)

Medium

Assumes RM pass-through in Q2-Q3; also incorporates capex ramp costs; lag risk if pass-through delayed

Consolidated EBITDA 18% expected (vs 16% Q1)

Medium

Depends on metal price stabilization; management noted if stable, margin reverts to prior 18.7%

China EBITDA 12-14% range; PAT ~6%

High

Stable margins demonstrated; Brownfield expansion expected to maintain similar profile

FY27 CapEx ₹50-80 Cr (Q1 ₹37 Cr)

High

Bhayla Phase-2 + China Phase-2 + regular maintenance; total ₹180-200 Cr over 2 years announced

Risks the call surfaced

Ranked by how much they should concern a holder

Margin recovery timing

High

RM pass-through lag extends margin pressure into H2 FY27; customer price resistance or competitive dynamics may prevent full recovery; OPM down 150 bps YoY.

Advantek ramp-up execution

High

₹140 Cr FY27 revenue target requires ~₹35 Cr/qtr burn-rate from current ₹30 Cr; PAT positive by FY27-end unproven; Phase-2 capex announced before Phase-1 fully ramped.

Romania profitability path

High

Losses continue despite topline growth; new management/strategy still in early stage; breakeven timeline pushed to 'maybe next year' (unverified); ₹2 Cr FX loss in Q1 masks operational issues.

Large-Cages ramp slowness

Medium

Q1 only ₹10 Cr despite 50% FY27 growth target; new facility ramping slower than expected; high-value segment at risk if ramp delays persist.

Japan customer deceleration

Medium

Q1 ₹21 Cr (+25% YoY) but FY27 guidance only 10% (₹80 Cr); slow project pipeline acknowledged; development conversion cycle lengthy unverified.

Management

Score 7/10. Transparent on headwinds (FX ₹4 Cr, RM ₹8 Cr, war ₹3 Cr); specific cost impacts quantified. Somewhat opaque on China/Romania separate financials (consolidated reporting). Credible on timing lag explanations. Hit prior double-digit revenue guidance; met/beat key product growth targets (Bushing 35%, Stamping 31%). Margin guidance walked down cautiously (24% → 20-22%), showing realism. Advantek and subsidiary recovery track record unproven.

What to watch next
  • 1 · Q2 FY27 (Oct 2026)

    RM cost pass-through impact visible; margin recovery signal

  • 2 · H2 FY27

    Advantek ramp accelerates toward ₹140 Cr annual run-rate target

  • 3 · Q3 FY28

    China brownfield expansion commissioned; FY29 full impact

Margin recovery hinges on RM pass-through timing and Advantek needing 3.25x growth in 9 months.

Informational and educational content only. Not investment advice.